D Spectrum - Diabetes Care - Am Diabetes Assoc Robert S. Rosenson (Chicago IL) discussed lipoprotein subclasses, inflammation,
and cardiovascular disease (CVD) risk in the metabolic syndrome. Insulin
resistance impairs VLDL particle clearance, leading to greater interchange ... Related articles
- ►ahajournals.org PJ Barter - Arteriosclerosis, thrombosis, and vascular biology, 2005 - Am Heart Assoc The cardiovascular benefits of treatment with fibrates appear to be greatest in
people with insulin resistance and other features of the metabolic syndrome. In
the HHS, a baseline level of serum triglyceride >200 mg/dL or a HDL ... Cited by 8 - Related articles - All 7 versions
JC Fruchart, B Staels, P Duriez - Bulletin de l'Académie nationale de médecine, 2001 - ncbi.nlm.nih.gov Peroxisome Proliferator-Activated Receptors (PPARs) have been discovered 10
years ago as being orphan nuclear receptors. Three subtypes of PPAR(s) have been
identified (alpha, gamma, delta). Activated PPARs bind to Peroxisome ... Cited by 4 - Related articles
RA Krasuski - Current opinion in lipidology, 2005 - journals.lww.com Purpose of review: Even with the aggressive reduction of LDL-cholesterol, the
risk of cardiovascular events in patients with coronary artery disease remains
substantial. The Armed Forces Regression Study was a randomized, ... Cited by 4 - Related articles - BL Direct - All 8 versions
- ►oxfordjournals.org SJ Nicholls, SE Nissen - European heart journal, 2005 - Eur Soc Cardiology Hydroxy-methyl glutaryl coenzyme A reductase inhibitors (statins) have
accumulated an extraordinary record of successful randomized clinical trials,
transforming the practice of preventive cardiology. However, most placebo- ... Cited by 5 - Related articles - All 5 versions
KG Parhofer - Der Kardiologe, 2008 - Springer DieTherapievonDyslipoproteinämienist ein wichtiger Bestandteil der Behandlung
von Atheroskleroseerkrankungen. Tra- ditionell steht bei der Beziehung Lipid-
stoffwechsel–Atherosklerose das LDL- Cholesterin im Mittelpunkt. Dies ... Related articles
- ►ahajournals.org SM Grundy - Circulation, 2004 - Am Heart Assoc Lowering low-density lipoproteins (LDL) by statin therapy to reduce the risk for
major clinical events in patients with established atherosclerotic
cardiovascular disease (ASCVD) represents a therapeutic triumph of modern ... Cited by 6 - Related articles - All 5 versions
- ►medscape.com CME Tracker - medscape.com Dr. Ridker's primary research brings together classic tools of large-scale,
population-based epidemiology with emerging genetic and molecular techniques
designed to improve our ability to predict and prevent thrombotic ... Related articles - All 5 versions
PDF Version - Médecine, 2006 - john-libbey-eurotext.fr Résumé : L'acide nicotinique est un "vieux" médicament qui a fait, sous sa
forme à libération immédiate, l'objet d'un essai de morbi-mortalité il ya 30
ans, le Coronary Drug Project. C'est aussi en France un "nouveau" ... Related articles - All 2 versions
